Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3421)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$509.92
Total Value
$101.98K
Shares Held After
324,843
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$508.76
Total Value
$325.61K
Shares Held After
325,043
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
920
Price
$507.14
Total Value
$466.57K
Shares Held After
325,683
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,679
Price
$506.16
Total Value
$849.84K
Shares Held After
326,603
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
961
Price
$505.18
Total Value
$485.48K
Shares Held After
328,282
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$503.83
Total Value
$80.61K
Shares Held After
329,243
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
440
Price
$502.93
Total Value
$221.29K
Shares Held After
329,403
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,519
Price
$501.88
Total Value
$762.35K
Shares Held After
329,843
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,328
Price
$500.93
Total Value
$665.24K
Shares Held After
331,362
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,253
Price
$500.08
Total Value
$626.60K
Shares Held After
332,690
% of Holdings
0.4%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
2,919
Price
$43.41
Total Value
$126.70K
Shares Held After
8,625
% of Holdings
25.3%
Maze Therapeutics, Inc. (MAZE)
Bernstein Harold — President, R&D&CMO
Shares
16,142
Price
$27.61
Total Value
$445.62K
Shares Held After
0
% of Holdings
100.0%
BioCardia, Inc. (BCDA)
Altman Peter — Director
Shares
1,900
Price
$0.92
Total Value
$1.75K
Shares Held After
375,785
% of Holdings
0.5%
Altimmune, Inc. (ALT)
Durso Jerome Benedict — Director
Shares
15,000
Price
$2.95
Total Value
$44.25K
Shares Held After
62,500
% of Holdings
24.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
951
Price
$71.50
Total Value
$68.00K
Shares Held After
494,887
% of Holdings
0.2%
Vericel Corp (VCEL)
MCLAUGHLIN KEVIN F — Director
Shares
7,000
Price
$44.53
Total Value
$311.71K
Shares Held After
18,300
% of Holdings
27.7%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
5,775
Price
$27.75
Total Value
$160.26K
Shares Held After
724,253
% of Holdings
0.8%
Cue Biopharma, Inc. (CUE)
Lin Shao-Lee — Director
Shares
34,225
Price
$26.99
Total Value
$923.73K
Shares Held After
730,028
% of Holdings
4.5%
Outlook Therapeutics, Inc. (OTLK)
Sukhtian Ghiath M. — Director
Shares
2,525,252
Price
$0.99
Total Value
$2.50M
Shares Held After
24,617,320
% of Holdings
10.3%
Disc Medicine, Inc. (IRON)
Yu Jonathan Yen-Wen — Chief Operating Officer
Shares
804
Price
$82.64
Total Value
$66.44K
Shares Held After
54,324
% of Holdings
1.5%
Tectonic Therapeutic, Inc. (TECX)
McNamara Peter — Chief Scientific Officer
Shares
43
Price
$35.00
Total Value
$1.50K
Shares Held After
55,285
% of Holdings
0.1%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
17,319
Price
$117.47
Total Value
$2.03M
Shares Held After
55,655
% of Holdings
23.7%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
18,208
Price
$116.49
Total Value
$2.12M
Shares Held After
72,974
% of Holdings
20.0%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
14,568
Price
$115.43
Total Value
$1.68M
Shares Held After
91,182
% of Holdings
13.8%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
3,605
Price
$114.70
Total Value
$413.48K
Shares Held After
105,750
% of Holdings
3.3%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
1,000
Price
$112.86
Total Value
$112.86K
Shares Held After
109,355
% of Holdings
0.9%
RHYTHM PHARMACEUTICALS, INC. (RYTM)
Mazabraud Yann — EVP, Head of International
Shares
2,300
Price
$111.80
Total Value
$257.14K
Shares Held After
110,355
% of Holdings
2.0%
Septerna, Inc. (SEPN)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
746,500
Price
$42.50
Total Value
$31.73M
Shares Held After
725,443
% of Holdings
50.7%
Septerna, Inc. (SEPN)
RA CAPITAL MANAGEMENT, L.P. — Director
Shares
746,500
Price
$42.50
Total Value
$31.73M
Shares Held After
4,777,415
% of Holdings
13.5%
Edgewise Therapeutics, Inc. (EWTX)
MOORE JOHN R — General Counsel
Shares
2,419
Price
$43.80
Total Value
$105.95K
Shares Held After
17,697
% of Holdings
12.0%
Edgewise Therapeutics, Inc. (EWTX)
MOORE JOHN R — General Counsel
Shares
99
Price
$44.50
Total Value
$4.41K
Shares Held After
20,116
% of Holdings
0.5%
Edgewise Therapeutics, Inc. (EWTX)
MOORE JOHN R — General Counsel
Shares
59
Price
$44.41
Total Value
$2.62K
Shares Held After
20,215
% of Holdings
0.3%
Edgewise Therapeutics, Inc. (EWTX)
MOORE JOHN R — General Counsel
Shares
2,439
Price
$43.81
Total Value
$106.85K
Shares Held After
20,274
% of Holdings
10.7%
Edgewise Therapeutics, Inc. (EWTX)
Derakhshan Behrad — Chief Business Officer
Shares
2,475
Price
$43.70
Total Value
$108.15K
Shares Held After
31,826
% of Holdings
7.2%
Edgewise Therapeutics, Inc. (EWTX)
Derakhshan Behrad — Chief Business Officer
Shares
150
Price
$44.44
Total Value
$6.67K
Shares Held After
34,301
% of Holdings
0.4%
Edgewise Therapeutics, Inc. (EWTX)
Derakhshan Behrad — Chief Business Officer
Shares
304
Price
$44.50
Total Value
$13.53K
Shares Held After
34,451
% of Holdings
0.9%
Edgewise Therapeutics, Inc. (EWTX)
Derakhshan Behrad — Chief Business Officer
Shares
2,171
Price
$43.79
Total Value
$95.08K
Shares Held After
34,755
% of Holdings
5.9%
Edgewise Therapeutics, Inc. (EWTX)
Russell Alan J — Director
Shares
390
Price
$44.46
Total Value
$17.34K
Shares Held After
31,466
% of Holdings
1.2%
Edgewise Therapeutics, Inc. (EWTX)
Russell Alan J — Director
Shares
2,273
Price
$43.68
Total Value
$99.28K
Shares Held After
31,856
% of Holdings
6.7%
Edgewise Therapeutics, Inc. (EWTX)
Russell Alan J — Director
Shares
3,238
Price
$43.68
Total Value
$141.43K
Shares Held After
34,129
% of Holdings
8.7%
Edgewise Therapeutics, Inc. (EWTX)
KOCH KEVIN — Director
Shares
913
Price
$44.33
Total Value
$40.47K
Shares Held After
52,488
% of Holdings
1.7%
Edgewise Therapeutics, Inc. (EWTX)
KOCH KEVIN — Director
Shares
8,276
Price
$43.66
Total Value
$361.32K
Shares Held After
53,401
% of Holdings
13.4%
Edgewise Therapeutics, Inc. (EWTX)
KOCH KEVIN — Director
Shares
8,782
Price
$43.64
Total Value
$383.25K
Shares Held After
61,677
% of Holdings
12.5%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
800
Price
$44.52
Total Value
$35.61K
Shares Held After
11,544
% of Holdings
6.5%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
104
Price
$44.43
Total Value
$4.62K
Shares Held After
12,344
% of Holdings
0.8%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
2,779
Price
$43.71
Total Value
$121.46K
Shares Held After
12,448
% of Holdings
18.3%
Edgewise Therapeutics, Inc. (EWTX)
Donovan Joanne M. — CMO
Shares
2,839
Price
$43.78
Total Value
$124.30K
Shares Held After
15,227
% of Holdings
15.7%
LIGAND PHARMACEUTICALS INC (LGND)
Haas Jason — Director
Shares
7,138
Price
$292.81
Total Value
$2.09M
Shares Held After
3,981
% of Holdings
64.2%
LIGAND PHARMACEUTICALS INC (LGND)
Espinoza Octavio — Chief Financial Officer
Shares
31,641
Price
$292.06
Total Value
$9.24M
Shares Held After
27,696
% of Holdings
53.3%
INCYTE CORP (INCY)
CAGNONI PABLO J — President, Global Head of R&D
Shares
10,803
Price
$120.04
Total Value
$1.30M
Shares Held After
194,001
% of Holdings
5.3%
Showing 151–200 of 3421 transactions (page 4 of 69)